Clinical trial
Open-Label Extension Study to Provide Access to ATH434 in Patients With Multiple System Atrophy
NCT07729852 is registered in ClinicalTrials.gov with Alterity Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label Extension Study to Provide Access to ATH434 in Patients With Multiple System Atrophy
- Lead sponsor
- Alterity Therapeutics
- Phase
- Phase 2
- Overall status
- Enrolling by invitation
- Start date
- October 1, 2026
- Completion date
- July 31, 2029
- Enrollment
- 7 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.